The stock has lost over 99% of its value in the past year, with the upcoming earnings report on Feb. 17 seen as a key test for the company’s growth narrative.
Trinseo recorded the biggest jump in retail chatter among materials stocks in the last 24 hours as users debated the company’s mixed results and ongoing restructuring efforts.
Signing Day Sports expects the proposed Swifty Global buy to enhance operational efficiency, reduce costs by over 50%, and accelerate product development.
While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival endpoints.
The brokerage also pointed to potential large-scale expansion opportunities and emphasized the growing acceptance of psychedelics in future treatment paradigms.
The company said it can now compete in the “high-volume/lower-price market, offering an amazing mix of TruGolf hardware and TruGolf software to golfers of any budget.”
Despite the earnings miss, Aehr Test Systems reiterated its fiscal 2025 guidance, targeting at least $70 million in revenue and a non-GAAP net profit before taxes of at least 10%.
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
After major chip-equipment manufacturer, ASML spooked the Tech world earlier this week with a weaker-than-expected earnings report, Taiwan Semiconductor has helped to right the ship this morning.
